Oxidative stress in Alzheimer disease: Synergy between the butterfield and Markesbery laboratories

NeuroMolecular Medicine

Volumn 13, Issue 1, 2011, Pages 19-22

  Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE;

ALZHEIMER DISEASE; DISEASE COURSE; HUMAN; LIPID PEROXIDATION; MEDICAL RESEARCH; MILD COGNITIVE IMPAIRMENT; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; UNITED STATES;

EID: 79952693726     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-010-8123-9     Document Type: Review

References (45)

1. MY Aksenov MV Aksenova DA Butterfield JW Geddes WR Markesbery 2001 Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 373 383 11246152 10.1016/S0306-4522(00)00580-7 1:CAS:528:DC%2BD3MXhslylu7c%3D (Pubitemid 32201924)
2. MY Aksenov MV Aksenova DA Butterfield WR Markesbery 2000 Oxidative modification of creatine kinase BB in Alzheimer's disease brain Journal of Neurochemistry 74 2520 2527 10820214 10.1046/j.1471-4159.2000.0742520.x 1:CAS:528:DC%2BD3cXjsVKrsLw%3D (Pubitemid 30314229)
3. D Boyd-Kimball H Mohmmad-Abdul T Reed R Sultana DA Butterfield 2004 Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity Chemical Research in Toxicology 17 1743 1749 15606152 10.1021/tx049796w 1:CAS:528:DC%2BD2cXhtVSqtr3M (Pubitemid 39665568)
4. D Boyd-Kimball HF Poon BC Lynn J Cai WM Pierce Jr JB Klein J Ferguson CD Link DA Butterfield 2006 Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human A β (1-42): Implications for Alzheimer's disease Neurobiology of Aging 27 1239 1249 16099075 10.1016/j.neurobiolaging.2005.07.001 1:CAS:528:DC%2BD28XntlClsL4%3D (Pubitemid 44067304)
5. D Boyd-Kimball R Sultana HF Poon BC Lynn F Casamenti G Pepeu JB Klein DA Butterfield 2005 Proteomic identification of proteins specifically oxidized by intracerebral injection of A β (1-42) into rat brain: implications for Alzheimer's disease Neuroscience 132 313 324 15802185 10.1016/j.neuroscience. 2004.12.022 1:CAS:528:DC%2BD2MXivVyqu7g%3D (Pubitemid 40417906)
6. DA Butterfield 2004 Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain Brain Research 1000 1 7 15053946 10.1016/j.brainres.2003.12.012 1:CAS:528:DC%2BD2cXisF2hsbs%3D (Pubitemid 38446484)
7. DA Butterfield D Boyd-Kimball A Castegna 2003 Proteomics in Alzheimer's disease: Insights into mechanisms of neurodegeneration Journal of Neurochemistry 86 1313 1327 12950441 10.1046/j.1471-4159.2003.01948.x 1:CAS:528: DC%2BD3sXnsV2itLo%3D (Pubitemid 37174249)
8. DA Butterfield A Castegna CM Lauderback J Drake 2002 Review: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contributes to neuronal death Neurobiology of Aging 23 655 664 12392766 10.1016/S0197-4580(01)00340-2 (Pubitemid 35217687)
9. DA Butterfield J Drake C Pocernich A Castegna 2001 Evidence of oxidative damage in Alzheimer's disease brain: Central role of amyloid β-peptide Trends in Molecular Medicine 7 548 554 11733217 10.1016/S1471-4914(01)02173-6 1:CAS:528:DC%2BD3MXovVCnu7o%3D (Pubitemid 33127140)
10. DA Butterfield V Galvan M Bader Lange H Tang RA Sowell P Spilman J Fombonne O Gorostiza J Zhang R Sultana DE Bredesen 2010 In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP Free Radical Biology and Medicine 48 136 144 19854267 10.1016/j.freeradbiomed.2009.10.035 1:CAS:528:DC%2BD1MXhsFyku7rL
11. DA Butterfield CM Lauderback 2002 Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress Free Radical Biology and Medicine 32 1050 1060 12031889 10.1016/S0891-5849(02)00794-3 1:CAS:528:DC%2BD38XjvVehur0%3D (Pubitemid 34603342)
12. DA Butterfield HF Poon D St. Clair JN Keller WM Pierce JB Klein WR Markesbery 2006 Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease Neurobiology of Disease 22 223 232 16466929 10.1016/j.nbd.2005.11.002 1:CAS:528:DC%2BD28XktVOqu7c%3D
13. DA Butterfield T Reed SF Newman R Sultana 2007 Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment Free Radical Biology and Medicine 43 658 677 17664130 10.1016/j.freeradbiomed.2007. 05.037 1:CAS:528:DC%2BD2sXotlSms7s%3D (Pubitemid 47102132)
14. DA Butterfield T Reed M Perluigi C De Marco R Coccia C Cini R Sultana 2006 Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neuroscience Letters 397 170 173 16413966 10.1016/j.neulet.2005.12.017 1:CAS:528:DC%2BD28XisFOqsrk%3D
15. DA Butterfield T Reed M Perluigi C De Marco R Coccia JN Keller WR Markesbery R Sultana 2007 Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease Brain Research 1148 243 248 17395167 10.1016/j.brainres.2007.02.084 1:CAS:528:DC%2BD2sXksVOqsLg%3D (Pubitemid 46602178)
16. DA Butterfield ER Stadtman 1997 Protein oxidation processes in aging brain Advantage of Cell Aging Gerontology 2 161 191 10.1016/S1566-3124(08)60057- 7 1:CAS:528:DyaK1cXlt1WnsLs%3D
17. DA Butterfield 2010 William R. Markesbery, M.D.: A legacy of excellence in Alzheimer's disease research and a life well-lived Journal of Alzheimer's Disease 20 3 4 20378955
18. A Castegna M Aksenov M Aksenova V Thongboonkerd JB Klein WM Pierce R Booze WR Markesbery DA Butterfield 2002 Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radical Biology and Medicine 33 562 571 12160938 10.1016/S0891-5849(02)00914-0 1:CAS:528:DC%2BD38XlvVWmtLs%3D (Pubitemid 34874977)
19. Castegna, A., Aksenov, Aksenova, M. M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R. Markesbery, W. R. & Butterfield, D. A. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: Dihydropyrimidinase-related protein 2, α-enolase, and heat shock cognate 71. Journal of Neurochemistry, 82, 1524-1532.
20. A Castegna V Thongboonkerd JB Klein B Lynn WR Markesbery DA Butterfield 2003 Proteomic identification of nitrated proteins in Alzheimer's disease brain Journal of Neurochemistry 85 1394 1401 12787059 10.1046/j.1471-4159.2003.01786.x 1:CAS:528:DC%2BD3sXkslOkt7k%3D (Pubitemid 36702552)
21. J Drake CD Link DA Butterfield 2003 Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model Neurobiology of Aging 24 415 420 12600717 10.1016/S0197-4580(02)00225-7 1:CAS:528:DC%2BD3sXhsVantbg%3D (Pubitemid 36210870)
22. K Hensley N Hall R Subramaniam P Cole M Harris M Aksenov M Aksenova SP Gabbita JF Wu JM Carney M Lovell WR Markesbery DA Butterfield 1995 Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation Journal of Neurochemistry 66 2146 2156
23. J Kanski M Aksenova C Schoneich DA Butterfield 2002 Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide (1-42) Free Radical Biology and Medicine 32 1205 1211 12031904 10.1016/S0891-5849(02)00821-3 1:CAS:528:DC%2BD38XjvVehu7Y%3D (Pubitemid 34603357)
24. JN Keller FA Schmitt SW Scheff Q Ding Q Chen DA Butterfield WR Markesbery 2005 Evidence of increased oxidative damage in subjects with mild cognitive impairment Neurology 64 1152 1156 15824339 1:CAS:528:DC%2BD2MXislSmu7k%3D
25. CM Lauderback JM Hackett FF Huang JN Keller LI Szweda WR Markesbery DA Butterfield 2001 The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: Role of A β 1-42 Journal of Neurochemistry 78 413 416 11461977 10.1046/j.1471-4159.2001.00451.x 1:CAS:528:DC%2BD3MXlsVeit74%3D (Pubitemid 32664423)
26. RL Levine D Garland CN Oliver A Amici AG Lenz BW Ahn S Shaltiel ER Stadtman 1990 Determination of carbonyl content in oxidatively modified proteins Methods in Enzymology 186 464 478 1978225 10.1016/0076-6879(90)86141-H 1:CAS:528:DyaK3MXksVGhtLY%3D (Pubitemid 20279989)
27. MA Lovell C Xie WR Markesbery 2001 Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures Neurobiology of Aging 22 187 194 11182468 10.1016/S0197-4580(00)00235-9 1:CAS:528: DC%2BD3MXht1yjsro%3D (Pubitemid 32162967)
28. 2+ homeostasis and cell death Journal of Neuroscience 15 6239 6249 7666206 1:CAS:528:DyaK2MXnvFChurs%3D
29. WR Markesbery 1997 Oxidative stress hypothesis in Alzheimer's disease Free Radical Biology and Medicine 23 134 147 9165306 10.1016/S0891-5849(96) 00629-6 1:CAS:528:DyaK2sXjtlaqs7o%3D (Pubitemid 27217017)
30. WR Markesbery MA Lovell 1998 Four-hydroxnonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiology of Aging 19 33 36 9562500 10.1016/S0197-4580(98)00009-8 1:CAS:528: DyaK1cXisFyrtLg%3D (Pubitemid 28167792)
31. WR Markesbery MA Lovell 2006 DNA oxidation in Alzheimer's disease Antioxidants & Redox Signaling 8 2039 2045 10.1089/ars.2006.8.2039 1:CAS:528:DC%2BD28XhtVKntb7N (Pubitemid 46489629)
32. H Mohmmad Abdul R St. Sultana DK Clair WR Markesbery DA Butterfield 2008 Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age Free Radical Biology and Medicine 45 1420 1425 10.1016/j.freeradbiomed.2008.08.012
33. H Mohmmad-Abdul R Sultana JN Keller DK St. Clair WR Markesbery DA Butterfield 2006 Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β -peptide (1-42), H2O2 and kainic acid: Implications for Alzheimer's disease Journal of Neurochemistry 96 1322 1335 16478525 10.1111/j.1471-4159.2005.03647.x
34. Perluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R. & Butterfield, D. A. (2009). Redox proteomics identification of HNE-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clinical Applications, 3, 682-693.
35. T Reed M Perluigi R Sultana WM Pierce DM Turner R Coccia WR Markesbery DA Butterfield 2008 Redox proteomic identification of 4-hydroxy-2-nonenal-modified proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease Neurobiology of Disease 30 107 120 18325775 10.1016/j.nbd.2007.12.007 1:CAS:528:DC%2BD1cXjs1Gruro%3D
36. EE Reich WR Markesbery LJ Roberts 2nd LL Swift JD Morrow TJ Montine 2001 Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease American Journal of Pathology 158 293 297 11141503 10.1016/S0002-9440(10)63968-5 1:CAS:528:DC%2BD3MXmsFOjsQ%3D%3D (Pubitemid 32096495)
37. CD Smith JM Carney PE Starke-Reed CN Oliver ER Stadtman RA Floyd WR Markesbery 2001 Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 88 10540 10543 10.1073/pnas.88.23.10540
38. R Sultana D Boyd-Kimball HF Poon J Cai WM Pierce JB Klein WR Markesbery DA Butterfield 2006 Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach Neurobiology of Disease 22 76 87 16378731 10.1016/j.nbd.2005.10.004 1:CAS:528:DC%2BD28XivVOjtbo%3D
39. R Sultana D Boyd-Kimball HF Poon J Cai WM Pierce JB Klein M Merchant WR Markesbery DA Butterfield 2006 Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD Neurobiology of Aging 27 1564 1576 16271804 10.1016/j.neurobiolaging.2005.09.021 1:CAS:528: DC%2BD28Xps1Oju70%3D (Pubitemid 44344840)
40. R Sultana A Ravagna H Mohmmad-Abdul V Calabrese DA Butterfield 2005 Ferulic acid ethyl ester protects neurons against amyloid β -peptide (1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity Journal of Neurochemistry 92 749 758 15686476 10.1111/j.1471-4159.2004. 02899.x 1:CAS:528:DC%2BD2MXhs1Kqt7s%3D (Pubitemid 40229546)
41. R Sultana T Reed M Perluigi R Coccia WM Pierce DA Butterfield 2007 Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: A regional study Journal of Cellular and Molecular Medicine 11 839 851 17760844 10.1111/j.1582-4934.2007.00065.x 1:CAS:528:DC%2BD2sXhtFSksrfE (Pubitemid 47313301)
42. S Varadarajan J Kanski M Aksenova C Lauderback DA Butterfield 2001 Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A β (1-42) and A β (25-35) Journal of the American Chemical Society 123 5625 5631 11403592 10.1021/ja010452r 1:CAS:528:DC%2BD3MXjvVWisrw%3D (Pubitemid 32904694)
43. SM Yatin CD Link DA Butterfield 1999 In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β -peptide (1-42) Neurobiology of Aging 20 325 330 10588580 10.1016/S0197-4580(99)00056-1 1:STN:280: DC%2BD3c%2Fltlyjsw%3D%3D (Pubitemid 29525418)
44. SM Yatin S Varadarajan DA Butterfield 2000 Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced protein oxidation and reactive oxygen species formation Journal of Alzheimer's Disease 2 123 131 12214102 1:CAS:528:DC%2BD3cXoslGmt7c%3D
45. SM Yatin M Yatin T Aulick KB Ain DA Butterfield 1999 Alzheimer's amyloid β -peptide generated free radicals increase rat embryonic neuronal polyamine uptake and ODC activity: Protective effect of vitamin E Neuroscience Letters 263 17 20 10218900 10.1016/S0304-3940(99)00101-9 1:CAS:528: DyaK1MXhvVCltrs%3D (Pubitemid 29138952)